Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,076–4,100 of 7,816 matching trials · page 164 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Low Dose IL2 Immunotherapy in AD NCT05821153 Aldesleukin Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 8 | The Methodist Hospital Research Institute OTHER |
2023-04-20 |
|
Cognitive Changes in Mild Cognitive Impairment NCT05821400 observational study Runs in: China · 1 site |
NA other |
UNKNOWN | 200 | Fujian Medical University Union Hospital OTHER |
2023-04-20 |
|
Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability NCT01041989 Nutritional guidance; Exercise; Cognitive training; Reduction of va... Runs in: Finland · 5 sites |
NA other |
UNKNOWN | 1,200 | Finnish Institute for Health and Welfare OTHER_GOV |
2023-04-19 |
|
PET Imaging of Subjects Using 124I-PU-AD NCT03371420 PU-AD; PET Scan; Blood Draws Runs in: United States · 1 site |
EARLY_PHASE1 other |
TERMINATED | 5 | Samus Therapeutics, Inc. INDUSTRY |
2023-04-18 |
|
A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects NCT03935568 PU-AD; Placebo; Placebo; PU-AD Runs in: United States · 1 site |
PHASE1 other |
TERMINATED | 40 | Samus Therapeutics, Inc. INDUSTRY |
2023-04-18 |
|
Predictive Indices of Independent Activity of Daily-living in Neurorehabilitation NCT04691102 Runs in: Italy · 1 site |
NA other |
UNKNOWN | 120 | I.R.C.C.S. Fondazione Santa Lucia OTHER |
2023-04-18 |
|
An Observational Study of Aducanumab-avwa in Participants With Alzheimer's Disease in the US NCT05097131 Runs in: United States · 22 sites |
NA anti-amyloid-antibody |
TERMINATED | 29 | Biogen INDUSTRY |
2023-04-18 |
|
Non-invasive Brain Stimulation by Transcranial Pulse Stimulation as a Coadjunctive Treatment in Alzheimer's Disease NCT05762926 Transcranial pulse stimulation (TPS) Runs in: Brazil · 1 site |
NA other |
UNKNOWN | 50 | University of Sao Paulo General Hospital OTHER |
2023-04-18 |
|
A Phase 2 Clinical Study to Explore the Optimal Dosage/Administration of PM012 Tablet in Alzheimer's Disease NCT05811000 PM012; PM012 Placebo; Donepezil; Donepezil placebo Runs in: South Korea · 1 site |
PHASE2|PHASE3 symptomatic-cholinergic |
UNKNOWN | 312 | Mediforum Ltd., Co. INDUSTRY |
2023-04-18 |
|
A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension NCT04187547 Tricaprilin; Placebo |
PHASE3 other |
WITHDRAWN | 0 | Cerecin INDUSTRY |
2023-04-14 |
|
Implementation of Cognitive Stimulation Therapy NCT04754932 Cognitive Stimulation Therapy Runs in: United States · 4 sites |
NA other |
COMPLETED | 23 | Duke University OTHER |
2023-04-14 |
|
Clinical Investigation EUCLIDES-01 for the Calculation of the Area of Skin Lesions NCT05729334 Clinicgram Euclides Runs in: Spain · 1 site |
NA other |
COMPLETED | 65 | Skilled Skin S.L. INDUSTRY |
2023-04-14 |
|
San Rocco Study: Implementation of the Non-pharmacological Therapies for People With Dementia Living in Nursing Home NCT05814276 Training on non-pharmacological therapies' methodology Runs in: Switzerland · 1 site |
NA other |
COMPLETED | 36 | Associazione Ginco Ticino OTHER |
2023-04-14 |
|
Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years. NCT05330871 1 Nebulized inhalation for booster groups; 2 Nebulized inhalation f... Runs in: China · 1 site |
PHASE2 other |
UNKNOWN | 410 | Seventh Medical Center of PLA General Hospital OTHER |
2023-04-13 |
|
MCI: CPAP Treatment of OSA (Memories2) NCT03113461 CPAP Runs in: United States · 4 sites |
NA other |
ACTIVE_NOT_RECRUITING | 327 | University of Pennsylvania OTHER |
2023-04-12 |
|
Environmental Design for Behavioral Regulation in People With Dementia NCT04555616 Standard Environmental Design; Individual Environmental Design; Placebo Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | Elizabeth K Rhodus OTHER |
2023-04-12 |
|
Study to Assess the Pharmacokinetics of CT1812 in Older Healthy Volunteers NCT05248672 CT1812 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 35 | Cognition Therapeutics INDUSTRY |
2023-04-12 |
|
iPACES v3 MCI NIA Protocol Copied for iPACES v4 PD NINDS NCT05810454 iPACES (interactive Physical and Cognitive Exercise System); PACE (... Runs in: United States · 1 site |
NA other |
UNKNOWN | 120 | iPACES LLC INDUSTRY |
2023-04-12 |
|
Preparation for End-of-Life Decision Making in Mild Dementia NCT03311711 SPIRIT-in person; SPIRIT-remote; Usual care Runs in: United States · 5 sites |
NA other |
COMPLETED | 242 | Emory University OTHER |
2023-04-11 |
|
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's Disease NCT05332678 SLS-005 - Once Weekly; SLS-005 - Twice Weekly Runs in: Australia · 3 sites |
PHASE2 other |
WITHDRAWN | 0 | Seelos Therapeutics, Inc. INDUSTRY |
2023-04-11 |
|
The Influence of Food for Special Dietary Use - Spread Enriched With 5-hydroxytryptophan, Theanine and Gamma-aminobutyric Acid on Psychophysiological Functions of Subjects Without Meaningful Organic and Cognitive Pathology NCT05543811 Food for special dietary use Runs in: Russia · 1 site |
NA other |
COMPLETED | 140 | Federal State Budgetary Scientific Institution OTHER_GOV |
2023-04-11 |
|
Investigation of Alzheimer's Disease and Periodontal Status NCT05807100 Baseline Standardized Mini Mental Test; 6th month Standardized Mini... Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 90 | Bezmialem Vakif University OTHER |
2023-04-11 |
|
Progression in Cognitive ADLs in Parkinson's Disease NCT05806866 Cognition scores, cognitive instrumental activities of daily living scores Runs in: Germany · 1 site |
NA other |
UNKNOWN | 130 | University Hospital Tuebingen OTHER |
2023-04-10 |
|
Amyloid Imaging With 11C-PiB in Healthy Aging and Mild Cognitive Impairment NCT04505735 11C-PiB Runs in: United States · 1 site |
NA other |
TERMINATED | 25 | University of Colorado, Denver OTHER |
2023-04-07 |
|
Validation of the I-UDS Neuropsychological Battery NCT05803122 Uniform Data Set (UDS) neuropsychological battery Runs in: Italy · 1 site |
NA other |
COMPLETED | 252 | IRCCS National Neurological Institute "C. Mondino" Foundation OTHER |
2023-04-07 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial